Initial in vivo tests of an electrohydraulic actuated total artificial heart.
The authors are involved in developing a total artificial heart (TAH) for permanent human use. This device was designed to fit human anatomy, and it has housings made of carbon fiber-epoxy composite and titanium. Tissue valves and protein coating of blood contacting surfaces minimize the need for anticoagulants. A continuously reciprocating electrohydraulic actuator is packaged between two alternately ejecting and passively filling ventricles. The control system varies the pump rate to maintain average left ventricular filling at 90%. This TAH in vivo successively progressed through 1, 5, 9, and 45 day implants in calves of 84, 94, 82, and 82 kg preoperative body weights. The operating modes include automatic and fixed rate. The chronic and acute effects of varying the right pump displaced stroke volume indicated the need for it to be limited to 85% of that of the left for stable hemodynamics at maximum flow. The pump exhibited afterload insensitive and preload sensitive performance. Pump output ranged from 4.0-9.5 L/min at left atrial pressures of 7-16 mmHg at pump rates of 80-160 beats/min in these four experiments. These data suggest that this device will meet clinical hemodynamic requirements; it has the potential for total implantable cardiac replacement.
Irié
H
H
Department of Biomedical Engineering and Applied Therapeutics, Cleveland Clinic Foundation, OH 44195.
Massiello
A
A
Kiraly
R
R
Chen
J F
JF
Crouch
R
R
Fukamachi
K
K
Jacobs
G
G
Harasaki
H
H
Golding
L
L
Thomas
D
D
D000818:Animals; D001698:Biomedical Engineering; D002417:Cattle; D005069:Evaluation Studies as Topic; D006354:Heart, Artificial / Q000009:adverse effects; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D011474:Prosthesis Design; D011475:Prosthesis Failure